HAINAN HULUWA PHARMACEUTICAL GROUP CO., LTD.

News Hainan Huluwa Pharmaceutical Group Co., Ltd.

Equities

605199

CNE100004223

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-14 pm EDT			5-day change	1st Jan Change
11.93 ^CNY	-0.75%		-2.05%	-21.31%

May. 01	Huluwa Pharmaceutical Gets Nod to Register Two Drugs	MT
Apr. 26	Hainan Huluwa Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Huluwa Pharmaceutical Gets Nod to Register Two Drugs	May. 01	MT
Hainan Huluwa Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 26	CI
Huluwa Pharma Gets Nod to Market Terbutaline Sulfate Inhaler	Apr. 23	MT
Huluwa Pharma Gets Nod to Register Cefdinir Granules	Feb. 20	MT
Huluwa Pharma Registers Ibuprofen Suspension	Jan. 17	MT
Huluwa Pharma Registers Hypertension Drug	Nov. 28	MT
Hainan Huluwa Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Huluwa Pharmaceutical Gets Nod to Trial Epilepsy Drug	23-09-22	MT
Hainan Huluwa Pharmaceutical Group Co., Ltd.(XSSC:605199) added to S&P Global BMI Index	23-09-18	CI
Hainan Huluwa Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28	CI
Hainan Huluwa Pharmaceutical Unit Gets Registration Certificate for Allergy Drug in China	23-08-04	MT
Huluwa Pharma's Supplementary Drug Application for Infection Treatment Wins Approval in China	23-06-06	MT
Hainan Huluwa Pharmaceutical Group Co., Ltd. completed the acquisition of 51% stake in Jiangxi Rongxing Pharmaceutical Co., Ltd. from Chen Xuerong.	23-04-19	CI
Hainan Huluwa Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-17	CI
Hainan Huluwa Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-17	CI
Hainan Huluwa Pharmaceutical Group Co., Ltd. entered into an agreement to acquire 51% stake in Jiangxi Rongxing Pharmaceutical Co., Ltd. from Chen Xuerong for CNY 44.88 million	23-03-16	CI
Hainan Huluwa Pharmaceutical Group Co., Ltd.(XSSC:605199) dropped from S&P Global BMI Index	22-12-19	CI
Huluwa Pharmaceutical Gets Regulatory Approval For Drug Production Line in China's Hainan Province	22-11-18	MT
Hainan Huluwa Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Hainan Huluwa Pharmaceutical Unit Acquires Marketing License of 50 Drugs; Shares Up 3%	22-10-27	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Hainan Huluwa Pharmaceutical Group Co., Ltd.

Equities

605199

CNE100004223

Summary

Filters